NR2C2_HUMAN - dbPTM
NR2C2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NR2C2_HUMAN
UniProt AC P49116
Protein Name Nuclear receptor subfamily 2 group C member 2
Gene Name NR2C2
Organism Homo sapiens (Human).
Sequence Length 596
Subcellular Localization Nucleus .
Protein Description Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear receptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior (By similarity). Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation..
Protein Sequence MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQPEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYRLARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MTSPSPRIQ
------CCCCCCCEE
49.7120860994
5Phosphorylation---MTSPSPRIQIIS
---CCCCCCCEEEEE
26.9517081983
12PhosphorylationSPRIQIISTDSAVAS
CCCEEEEECCCCCCC
27.9923927012
13PhosphorylationPRIQIISTDSAVASP
CCEEEEECCCCCCCC
24.4623927012
13 (in isoform 2)Phosphorylation-24.4624719451
15 (in isoform 2)Phosphorylation-25.4027251275
15PhosphorylationIQIISTDSAVASPQR
EEEEECCCCCCCCCE
25.4023927012
19 (in isoform 2)Phosphorylation-18.2428985074
19PhosphorylationSTDSAVASPQRIQIV
ECCCCCCCCCEEEEE
18.2429255136
27PhosphorylationPQRIQIVTDQQTGQK
CCEEEEEECCCCCCE
29.7120068231
37 (in isoform 2)Phosphorylation-3.1925627689
38 (in isoform 2)Phosphorylation-1.2925627689
39PhosphorylationGQKIQIVTAVDASGS
CCEEEEEEEEECCCC
23.6928464451
44PhosphorylationIVTAVDASGSPKQQF
EEEEEECCCCCCEEE
35.0330266825
46PhosphorylationTAVDASGSPKQQFIL
EEEECCCCCCEEEEE
26.8229255136
54PhosphorylationPKQQFILTSPDGAGT
CCEEEEEECCCCCCC
33.1430266825
55PhosphorylationKQQFILTSPDGAGTG
CEEEEEECCCCCCCC
19.9730266825
61PhosphorylationTSPDGAGTGKVILAS
ECCCCCCCCEEEEEC
33.0429255136
63UbiquitinationPDGAGTGKVILASPE
CCCCCCCEEEEECCC
26.41-
65 (in isoform 2)Phosphorylation-2.7924719451
68PhosphorylationTGKVILASPETSSAK
CCEEEEECCCCCCCC
21.5930266825
71PhosphorylationVILASPETSSAKQLI
EEEECCCCCCCCEEE
31.2230266825
72O-linked_GlycosylationILASPETSSAKQLIF
EEECCCCCCCCEEEE
27.0031492838
72PhosphorylationILASPETSSAKQLIF
EEECCCCCCCCEEEE
27.0030266825
73PhosphorylationLASPETSSAKQLIFT
EECCCCCCCCEEEEE
47.0830266825
73 (in isoform 2)Phosphorylation-47.0827251275
82 (in isoform 2)Ubiquitination-22.80-
87 (in isoform 2)Phosphorylation-29.5224719451
94PhosphorylationPGRIQIVTDSASVER
CCCEEEEECCHHHHH
26.3530266825
96PhosphorylationRIQIVTDSASVERLL
CEEEEECCHHHHHHH
17.0530266825
98PhosphorylationQIVTDSASVERLLGK
EEEECCHHHHHHHCC
28.5930266825
115 (in isoform 2)Phosphorylation-34.0724719451
116PhosphorylationQRPQVVEYCVVCGDK
CCCEEEEEEEEECCC
4.48-
117 (in isoform 2)Phosphorylation-0.8727251275
189PhosphorylationMKMESVQSERKPFDV
CCHHHHHCCCCCCCC
36.8928555341
192UbiquitinationESVQSERKPFDVQRE
HHHHCCCCCCCCCCC
46.08-
192SumoylationESVQSERKPFDVQRE
HHHHCCCCCCCCCCC
46.0828112733
200AcetylationPFDVQREKPSNCAAS
CCCCCCCCCCCCCCC
56.8025953088
207PhosphorylationKPSNCAASTEKIYIR
CCCCCCCCCCEEEEE
20.6928348404
208PhosphorylationPSNCAASTEKIYIRK
CCCCCCCCCEEEEEC
36.2528985074
219PhosphorylationYIRKDLRSPLIATPT
EEECCCCCCCEECCC
31.2129255136
224PhosphorylationLRSPLIATPTFVADK
CCCCCEECCCEEECC
18.8325159151
226PhosphorylationSPLIATPTFVADKDG
CCCEECCCEEECCCC
26.7921712546
231UbiquitinationTPTFVADKDGARQTG
CCCEEECCCCCCCCC
48.61-
231AcetylationTPTFVADKDGARQTG
CCCEEECCCCCCCCC
48.6123954790
238 (in isoform 2)Phosphorylation-18.8624719451
243 (in isoform 2)Phosphorylation-23.0224719451
322PhosphorylationTLAKALNTTDSSSSP
HHHHHHCCCCCCCCC
32.6029978859
323PhosphorylationLAKALNTTDSSSSPS
HHHHHCCCCCCCCCC
32.5829978859
325PhosphorylationKALNTTDSSSSPSLA
HHHCCCCCCCCCCCC
29.9929978859
326PhosphorylationALNTTDSSSSPSLAD
HHCCCCCCCCCCCCC
37.3329978859
327PhosphorylationLNTTDSSSSPSLADG
HCCCCCCCCCCCCCC
50.6625850435
328PhosphorylationNTTDSSSSPSLADGI
CCCCCCCCCCCCCCE
22.0623401153
330PhosphorylationTDSSSSPSLADGIDT
CCCCCCCCCCCCEEC
37.8328464451
337PhosphorylationSLADGIDTSGGGSIH
CCCCCEECCCCCEEE
27.6129978859
338PhosphorylationLADGIDTSGGGSIHV
CCCCEECCCCCEEEE
31.5229978859
342PhosphorylationIDTSGGGSIHVISRD
EECCCCCEEEEEECC
16.8829978859
346 (in isoform 2)Phosphorylation-1.4024719451
347 (in isoform 2)Phosphorylation-28.8127251275
347PhosphorylationGGSIHVISRDQSTPI
CCEEEEEECCCCCCE
28.8129978859
351PhosphorylationHVISRDQSTPIIEVE
EEEECCCCCCEEEEE
40.2029255136
352PhosphorylationVISRDQSTPIIEVEG
EEECCCCCCEEEEEC
16.9329255136
363PhosphorylationEVEGPLLSDTHVTFK
EEECCCCCCCEEEEE
48.4223403867
365PhosphorylationEGPLLSDTHVTFKLT
ECCCCCCCEEEEEEE
18.1823403867
368PhosphorylationLLSDTHVTFKLTMPS
CCCCCEEEEEEECCC
13.8823403867
370 (in isoform 2)Phosphorylation-33.4127251275
371 (in isoform 2)Phosphorylation-4.3024719451
516UbiquitinationTSTSQIEKFQEKAQM
CCHHHHHHHHHHHHH
54.71-
531UbiquitinationELQDYVQKTYSEDTY
HHHHHHHHHCCHHHH
39.11-
550 (in isoform 2)Ubiquitination-4.00-
571PhosphorylationTGLIGNVSIDSIIPY
CCCCCCEEHHHHHHH
25.36-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
19SPhosphorylationKinaseMAPK-FAMILY-GPS
19SPhosphorylationKinaseMAPK-Uniprot
55SPhosphorylationKinaseMAPK-Uniprot
68SPhosphorylationKinaseMAPK-FAMILY-GPS
68SPhosphorylationKinaseMAPK-Uniprot
-KUbiquitinationE3 ubiquitin ligaseTRAF6Q9Y4K3
PMID:15492226

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
19SPhosphorylation

19690332
68SPhosphorylation

20068231

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NR2C2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HDAC3_HUMANHDAC3physical
12943985
HDAC4_HUMANHDAC4physical
12943985
ESR1_HUMANESR1physical
11844790
ANDR_HUMANARphysical
10611280
HNF4A_HUMANHNF4Aphysical
12522137
RXRB_HUMANRXRBphysical
15604093
TAB1_HUMANTAB1physical
22158122
PDLI7_HUMANPDLIM7physical
16446357
TAB2_HUMANTAB2physical
20064081
TRAF6_HUMANTRAF6physical
20064081
JAZF1_HUMANJAZF1physical
15302918
NR2C2_HUMANNR2C2physical
15302918
KDM1A_HUMANKDM1Aphysical
23455924
DDB1_HUMANDDB1physical
24703702
DCAF1_HUMANVPRBPphysical
24703702
CUL4B_HUMANCUL4Bphysical
24703702
S10A4_HUMANS100A4physical
26496610
SMRC1_HUMANSMARCC1physical
26496610
EED_HUMANEEDphysical
26496610
RPP38_HUMANRPP38physical
26496610
PATZ1_HUMANPATZ1physical
26496610
TANC2_HUMANTANC2physical
26496610
RBMX2_HUMANRBMX2physical
26496610
PR40A_HUMANPRPF40Aphysical
26496610
KLHL7_HUMANKLHL7physical
26496610
UBB_HUMANUBBphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NR2C2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-46, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219 AND THR-224, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY.

TOP